HomeDYN • NASDAQ
add
Dyne Therapeutics Inc
Previous close
$13.61
Day range
$12.28 - $13.70
Year range
$12.28 - $47.45
Market cap
1.25B USD
Avg Volume
2.16M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 97.11M | 43.46% |
Net income | -89.54M | -34.37% |
Net profit margin | — | — |
Earnings per share | -0.88 | 19.27% |
EBITDA | -96.66M | -43.65% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 642.27M | 421.74% |
Total assets | 691.23M | 318.72% |
Total liabilities | 61.40M | -16.80% |
Total equity | 629.84M | — |
Shares outstanding | 113.12M | — |
Price to book | 2.21 | — |
Return on assets | -33.25% | — |
Return on capital | -35.08% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -89.54M | -34.37% |
Cash from operations | -84.34M | -140.92% |
Cash from investing | -16.01M | -161.12% |
Cash from financing | 3.64M | 2,373.47% |
Net change in cash | -96.71M | -1,016.35% |
Free cash flow | -56.17M | -422.84% |
About
Founded
2017
Headquarters
Website
Employees
191
